Efficacy and tolerability of duvelisib in relapsed/refractory peripheral T-cell lymphoma: A multicenter real-world analysis.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Priyanka Pullarkat, Kishan Kamlesh Patel, Alison J. Moskowitz, Omar Elghawy, Stefan K. Barta, Josie Ford, Salvia Jain, Lauren Shea, Shambhavi Singh, Jie Wang, Fatima Tuz Zahra, Yumeng Zhang, Neha Akkad, Swaminathan P. Iyer, Alexander Daniel Sanjurjo, Seda S. Tolu, Matthew Alexander Lunning, Bret Wankel, Conner Liddle, Neha Mehta-Shah
Institutions: Washington University in St. Louis, Memorial Sloan Kettering Cancer Center, Hospital of the University of Pennsylvania, University of Pennsylvania Health System, Massachusetts General Hospital, University of Alabama at Birmingham, Duke University Hospital, Duke University, Duke Cancer Institute, University of South Florida, Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center, Columbia University Irving Medical Center, Columbia University, University of Nebraska Medical Center, University of Rochester, University of Utah
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162489568
Cites:
Cited by:
Related to: